Seeking Alpha

Orexigen Therapeutics (OREX) shares are currently halted following the announcement that its...

Orexigen Therapeutics (OREX) shares are currently halted following the announcement that its meeting with senior FDA officials culminated with a written correspondence detailing design requirements that will allow them to reinitiate development of its cardiovascular drug Contrave. Shares +100% prior to trading halt, will resume trading at 4:30 pm EST.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs